Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Kursexplosion von 383 % seit November und massiver Solana-Outperformer!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 904604 | ISIN: CA3359341052 | Ticker-Symbol: IZ1
Tradegate
22.01.25
10:42 Uhr
12,720 Euro
-0,098
-0,76 %
Branche
Rohstoffe
Aktienmarkt
S&P/TSX 60
1-Jahres-Chart
FIRST QUANTUM MINERALS LTD Chart 1 Jahr
5-Tage-Chart
FIRST QUANTUM MINERALS LTD 5-Tage-Chart
RealtimeGeldBriefZeit
12,70012,90212:36
12,71212,90212:15
PR Newswire
166 Leser
Artikel bewerten:
(1)

ID Quantique's Clavis XG: The World's First Quantum Key Distribution (QKD) Product to Obtain National Security Certification

Finanznachrichten News

GENEVA, Jan. 22, 2025 /PRNewswire/ -- ID Quantique (IDQ), a global leader in Quantum-Safe solutions and Quantum Communications, today announced that its high-performance Clavis XG series, has become the first product of its class globally to receive an official national security approval from South Korea's National Intelligence Service (NIS).

ID Quantique's Clavis XG

The QKD evaluation program of Clavis XG encompassed both the QKD system and the embedded Quantum Key Management platform (QKMS), Clarion KX. It was designed in collaboration with the Ministry of Science and ICT, and the evaluation testing and validation were performed in collaboration with the National Security Research Institute (NSR), the Korea Research Institute of Standards and Science (KRISS), the Korea Information and Communication Technology Association (TTA), and the IT Security Certification Center (ITSCC), a CC (Common Criteria) certification body responsible for national security evaluation and related regulations, as well as the management of Common Criteria Recognition Arrangement (CCRA).

This national accreditation acknowledges Clavis XG as the first quantum-safe cryptography system based on quantum-physics and BB84 QKD protocol to meet stringent national security standards, setting a new milestone in the global quantum cryptography market.

While most government organizations must follow the guidelines and policies of their respective national security authorities, NSR's multi-year security evaluation effort marks a significant milestone for the global QKD industry. IDQ will continue to support the undergoing international efforts for a standardized evaluation of quantum-physics based security solutions. Independent security accreditation programs that are designed and performed by experts in national security test labs enable a higher degree of confidence necessary for the migration to quantum-safe communication across enterprise and government sectors.

Grégoire Ribordy, CEO of ID Quantique, stated, "This is a massive leap forward for QKD, a physics-based quantum cryptography technology, which has successfully evolved and matured into a telecom grade security solution. We are thrilled to be able to support the cybersecurity strategy of our customers who seek to combine QKD with Post-Quantum Cryptography to mitigate the Quantum threat. The adoption of Clavis XG and Clarion KX platform will expand rapidly in the areas requiring high-level security, such as government, financial services, energy, critical infrastructure, and healthcare verticals."

The QKD approval program included rigorous and comprehensive evaluation of optical and digital subsystems of Clavis XG, as well as the software stack and protocols of the embedded Quantum Key Management System, Clarion KX.

The Clavis XG Series has already proved itself in a wide range of deployments in telecommunication network infrastructures and data centers, meeting and exceeding customers' performance requirements. With a compact 19' rackmount 1U size, it offers the most advanced footprint in the market. Importantly, our partner interoperability program ensures our customers can immediately benefit from seamless integration with the industry leading range of network encryptors, network operation management suites, and SDNs. Together with the embedded and NIST-approved QRNG as well as the Clarion KX Quantum Key Management suite, a field proven and robust platform for complex network topologies and high SLA deployments, IDQ's partners and customers can now accelerate a cost-effective migration of network infrastructure to Quantum-Safe.

About ID Quantique
Founded in 2001, ID Quantique is the world leader in quantum-safe crypto solutions, designed to protect data for the future. The company provides quantum-safe network encryption, secure quantum key generation and Quantum Key Distribution solutions and services to the financial industry, enterprises, and government organizations globally. IDQ's quantum random number generator has been validated according to global standards and independent agencies and is the reference in highly regulated and mission-critical industries such as security, encryption, critical infrastructure and IoT - where trust is paramount.

Photo - https://mma.prnewswire.com/media/2602920/ID_Quantique_Clavis_XG.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/id-quantiques-clavis-xg-the-worlds-first-quantum-key-distribution-qkd-product-to-obtain-national-security-certification-302357209.html

© 2025 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.